NEW YORK ( TheStreet) -- Shares of China Pharma (AMEX: CPHI) have taken a tremendous swing upward. The stock is trading at $2.25 as of 3:55 p.m. ET, 20.3% above Tuesday's closing price of $1.87. Volume is at 128,681, 1.6 times the daily average of 81,500. China has a market cap of $79.4 million and is part of the health care sector and drugs industry. Shares are down 38.3% year to date as of the close of trading on Tuesday. China Pharma Holdings, Inc., through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., manufactures, markets, and sells pharmaceuticals and nutritional supplements to hospitals and retailers in the People's Republic of China. The company has a P/E ratio of 3.3, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates China as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full China Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center. Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.